Category Archives: Specialty Drug

PANTHERx and Amber Specialty Pharmacy Selected by ChemoCentryx to Dispense Tavneos

ChemoCentryx selected only Amber Specialty Pharmacy and PANTHERx as its limited distribution network for Tavenos

Syneos Health Increases Data Analytics Capabilities with RxDataScience Acquisition

Syneos Health recently announced the acquisition of RxDataScience, a leading healthcare-focused data analytics, data management and artificial intelligence (AI) company

AllianceRx Walgreens Prime Dispensing Arcalyst and Gavreto

AllianceRx Walgreens Prime (AllianceRx) is offering Arcalyst (rilonacept) and Gavreto (pralsetinib), two medicines prescribed for the treatment of specific kinds of cancer as well as an autoinflammatory cardiovascular disease

Veradigm and CareMetx Partner to Optimize Specialty Medication Access

Many hub service providers and other companies develop patient support platforms to offer patient-centric capabilities in order to provide better services that improve patient outcomes

GBT’s Oxbryta® Accepted by FDA for Priority Review for Pediatric Sickle Cell Disease

The FDA has accepted for Priority Review the supplemental New Drug Application (sNDA) for voxelotor (Oxbryta®) for the treatment of sickle cell disease in patients aged 4 to 11 years

Indegene Acquires Medical Marketing Economics (MME)

Indegene has acquired market-access advisory Medical Marketing Economics (MME) for $10 million, as it seeks to bolster its biopharma pricing and reimbursement capabilities

AstraZeneca’s Saphnelo to Compete with GSK’s Benlysta to Treat Lupus

Saphnelo, while primarily available through the leading specialty drug distributors, is also available through Amber Specialty Pharmacy and US Bioservices